Over the past few decades, rapid progress in both tissue engineering and regenerative medicine has revolutionized approaches to tissue regeneration and ...

Candel Therapeutics, Inc. (NASDAQ:CADL) has secured FDA Regenerative Medicine Advanced Therapy (RMAT) designation for its ...

The FDA's RMAT designation is intended to expedite the development and review of regenerative medicine therapies intended to treat, modify, reverse, or cure serious or life-threatening diseases where ...

Shares of Candel Therapeutics, Inc. (CADL) traded 8% higher on Wednesday morning after the U.S. Food and Drug Administration ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

Since the COVID-19 pandemic, global interest in antiviral therapies has increased significantly. Recently, with the growing ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Since the COVID-19 pandemic, global interest in antiviral therapies has increased significantly. Recently, with the growing ...

Laminin 521 (Cat. No. GMP-LA5H24) successfully maintained rapid expansion of human iPSCs, enabling cell passaging after just ...

Cardiac regenerative medicine represents a promising strategy aimed at restoring impaired heart function by replacing or ...

The use of a regenerative medicine, specifically a CAR T-cell therapy ... addition to being eligible for rolling submission and priority review of the marketing application. “It’s gratifying to see ...